Showing results (1-10 of 56) with videos related to
Sort By:
Pageof 6
Bulletin of the NYU Hospital for Joint Diseases|November 1, 2011
Interleukin 6 inhibition - RA and beyondRobert S Woodrick, Eric M RudermanBulletin of the NYU Hospital for Joint Diseases|December 25, 2012
IL-6 inhibition for the treatment of rheumatoid arthritis and other conditionsRobert S Woodrick, Eric M RudermanNature Reviews. Rheumatology|October 13, 2011
Safety of biologic therapy in rheumatoid arthritisRobert S Woodrick, Eric M RudermanCurrent Pharmaceutical Design|February 22, 2005
Current and future pharmaceutical therapy for rheumatoid arthritisEric M RudermanRheumatology (Oxford, England)|December 11, 2012
Overview of safety of non-biologic and biologic DMARDsEric M RudermanJournal of the American Academy of Dermatology|August 2, 2003
Evaluation and management of psoriatic arthritis: the role of biologic therapyEric M RudermanBulletin of the Hospital for Joint Disease (2013)|October 25, 2013
Treating to target in rheumatoid arthritis - challenges and opportunitiesEric M RudermanBulletin of the Hospital for Joint Disease (2013)|November 14, 2013
The role of concomitant methotrexate in biologic therapy for rheumatoid arthritisEric M RudermanThe American Journal of Managed Care|May 7, 2002
Current perspectives in the recognition and management of psoriatic arthritis: implications for integrated patient careEric M RudermanPageof 6